Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
4
×
fda
life sciences
national blog main
4
×
boston blog main
eli lilly
indiana blog main
new york blog main
san francisco blog main
startups
type 1 diabetes
beta bionics
boston top stories
deals
indiana top stories
investing
medical device
new york top stories
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
software
adaptive biotechnologies
alector
allergan
ame cloud ventures
american diabetes association
amgen
apollomics
arrowmark partners
bernie sanders
bigfoot biomedical
bill & melinda gates foundation trust
black diamond therapeutics
boehringer ingelheim
boston
boston university
boulder/denver blog main
What
diabetes
4
×
blood
eli
levels
medical
patients
sugar
appetite
approval
available
balance
beta
bid
bio
biome
bionics
black
boehringer
bread
butter
buyout
cancer
cash
closed
developing
device
diamond’s
driven
drug
drugs
expand
eyes
fallen
fda
food
giant
grabbed
hasn’t
heads
healthy
Language
unset
Current search:
diabetes
×
" clinical trials "
×
" national blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
5 years ago
With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests